169 related articles for article (PubMed ID: 27647675)
21. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
22. Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication.
Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K; Weseslindtner L
J Clin Virol; 2019 Nov; 120():6-11. PubMed ID: 31505316
[TBL] [Abstract][Full Text] [Related]
23. Urothelial cell carcinoma after BK polyomavirus infection in kidney transplant recipients: A cohort study of veterans.
Rogers R; Gohh R; Noska A
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28727230
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
[TBL] [Abstract][Full Text] [Related]
25. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
26. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent.
Geetha D; Tong BC; Racusen L; Markowitz JS; Westra WH
Transplantation; 2002 Jun; 73(12):1933-6. PubMed ID: 12131691
[TBL] [Abstract][Full Text] [Related]
27. BK polyomavirus infection promotes growth and aggressiveness in bladder cancer.
Zeng Y; Sun J; Bao J; Zhu T
Virol J; 2020 Sep; 17(1):139. PubMed ID: 32928222
[TBL] [Abstract][Full Text] [Related]
28. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
[TBL] [Abstract][Full Text] [Related]
29. BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients.
Demey B; Descamps V; Presne C; Helle F; Francois C; Duverlie G; Castelain S; Brochot E
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672313
[TBL] [Abstract][Full Text] [Related]
30. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
Kaur A; Wilhelm M; Wilk S; Hirsch HH
Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
[TBL] [Abstract][Full Text] [Related]
31. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
Madden K; Janitell C; Sower D; Yang S
Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
[TBL] [Abstract][Full Text] [Related]
32. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.
Virtanen E; Seppälä H; Helanterä I; Laine P; Lautenschlager I; Paulin L; Mannonen L; Auvinen P; Auvinen E
J Clin Virol; 2018 May; 102():70-76. PubMed ID: 29518695
[TBL] [Abstract][Full Text] [Related]
33. Adverse impact of pretransplant polyoma virus infection on renal allograft function.
Hayat A; Mukhopadhyay R; Radhika S; Sachdeva MS; Nada R; Joshi K; Sakhuja V; Jha V
Nephrology (Carlton); 2008 Apr; 13(2):157-63. PubMed ID: 18275505
[TBL] [Abstract][Full Text] [Related]
34. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Hirsch HH; Randhawa PS;
Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
[TBL] [Abstract][Full Text] [Related]
35. BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model.
Alexiev BA; Randhawa P; Vazquez Martul E; Zeng G; Luo C; Ramos E; Drachenberg CB; Papadimitriou JC
Hum Pathol; 2013 May; 44(5):908-17. PubMed ID: 23317548
[TBL] [Abstract][Full Text] [Related]
36. Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.
Teutsch K; Schweitzer F; Knops E; Kaiser R; Pfister H; Verheyen J; Göbel H; Cingöz T; Di Cristanziano V
Med Microbiol Immunol; 2015 Dec; 204(6):657-64. PubMed ID: 25749892
[TBL] [Abstract][Full Text] [Related]
37. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
38. The human polyomavirus BK (BKPyV): virological background and clinical implications.
Rinaldo CH; Tylden GD; Sharma BN
APMIS; 2013 Aug; 121(8):728-45. PubMed ID: 23782063
[TBL] [Abstract][Full Text] [Related]
39. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
[TBL] [Abstract][Full Text] [Related]
40. Late-onset BK viral nephropathy in a kidney transplant recipient.
Mathew JC; Holanda DG; Figanbaum TL; Fraer M; Thomas CP
Transplant Proc; 2014 Sep; 46(7):2386-90. PubMed ID: 25242792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
